Näytä suppeat kuvailutiedot

dc.contributor.advisorJalasvuori, Matti
dc.contributor.advisorGiven, Cindy
dc.contributor.authorTelimaa, Heta
dc.date.accessioned2023-09-11T05:52:36Z
dc.date.available2023-09-11T05:52:36Z
dc.date.issued2023
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/89009
dc.description.abstractUrinary tract infections (UTIs) are one of the most common bacterial infections in the world. The majority of UTIs are caused by uropathogenic E. coli (UPEC) which tend to live in surface-attached microbe communities, known as biofilms. Urinary tract infections can be cured with antibiotics, generally with good success. However, increased antibiotic resistance has led to a rise of recurrent UTIs and biofilms are in fact known to reduce the effect of antibiotics. One potential alternative to treat such infections in the future is phage therapy, i.e., using viruses that kill bacteria. The aim of this study was to find out how different bacteriophages (phages) can eliminate three different UPEC strains (EC7, EC10, EC38) growing in biofilms. Five different phages were produced for each strain. Biofilms of each strain were grown in the pegs of 96-well plate lids and then further treated with two different concentrations of phage lysates. In the experiment were studied not only the potential of individual phages, but also their combined effect in pairs and in a cocktail of five phages. The results were obtained by measuring the optical density at a wavelength of 600 nm every 30 minutes for 24 hours using Tecan Spark® microplate reader. The study shows that several treatments effectively reduce bacterial growth and thus, proves the potential of phage therapy as an effective novel approach. When the results are further consider together with a parallel antibiotic study, it is clear that phage therapy is a promising alternative for the treatment of bacterial infections, especially when combined with antibiotic treatment.en
dc.format.extent31
dc.language.isoen
dc.rightsIn Copyright
dc.titlePotential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
dc.typemaster thesis
dc.identifier.urnURN:NBN:fi:jyu-202309115037
dc.type.ontasotMaster’s thesisen
dc.type.ontasotPro gradu -tutkielmafi
dc.contributor.tiedekuntaMatemaattis-luonnontieteellinen tiedekuntafi
dc.contributor.tiedekuntaFaculty of Sciencesen
dc.contributor.laitosBio- ja ympäristötieteiden laitosfi
dc.contributor.laitosDepartment of Biological and Environmental Scienceen
dc.contributor.yliopistoJyväskylän yliopistofi
dc.contributor.yliopistoUniversity of Jyväskyläen
dc.contributor.oppiaineSolu- ja molekyylibiologiafi
dc.contributor.oppiaineCell and molecular biologyen
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.rights.copyright© The Author(s)
dc.rights.accesslevelopenAccess
dc.type.publicationmasterThesis
dc.contributor.oppiainekoodi4013
dc.subject.ysobakteriofagit
dc.subject.ysofagiterapia
dc.subject.ysoantibioottiresistenssi
dc.subject.ysovirtsatieinfektio
dc.subject.ysomikrobiologia
dc.subject.ysokolibakteerit
dc.subject.ysobacteriophages
dc.subject.ysophage therapy
dc.subject.ysoantibiotic resistance
dc.subject.ysourinary tract infection
dc.subject.ysomicrobiology
dc.subject.ysoEscherichia coli
dc.rights.urlhttps://rightsstatements.org/page/InC/1.0/


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

In Copyright
Ellei muuten mainita, aineiston lisenssi on In Copyright